Product
AZD4205
2 clinical trials
2 indications
Indication
Healthy SubjectsClinical trial
A Phase I/II, Open-Label, Multicentre Study to Investigate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD4205 in Patients With Peripheral T Cell Lymphoma (PTCL)Status: Completed, Estimated PCD: 2023-10-12
Clinical trial
A Phase 1, Single-Center, Nonrandomized, Open-Label, 2-Part, Fixed-Sequence, Drug-Drug Interaction Study to Assess the Pharmacokinetics and Safety of AZD4205 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2022-10-08